Leucovorin for the Treatment of Language Impairment in Children with Autism Spectrum Disorder

Research Study

The Massachusetts General Hospital is conducting a study investigating the safety and effectiveness of a medication called leucovorin to improve language in children with autism spectrum disorders (ASD). Participants must be between ages 5 and 12, with an autism spectrum disorder. This study will include several visits to the MGH Lurie Center. Participants will receive study medication and all study-related evaluations at no charge. Participants will be compensated up to $200 for their time.

For additional information about study requirements and study procedures, please contact the Lurie Center research staff at 781-860-1711 or LurieCenterResearch@partners.org.

Published on: Jan 19, 2021 at 09:44

— Back to Research Studies —